PODCAST · business
MAP - Market Access Podcast
by Dr. Stefan Walzer
Market Access (or alternatively reimbursement) in health care is THE key competence in order to be commercially successful with a new drug, medical device or digital health application. However, given the fact that market access is a complex field involving various disciplines and is an ever-changing field, it is difficult to be up to speed with the different evolvements across the world. MAP is THE bi-weekly Market Access Podcast provided by MArS Market Access & Pricing Strategy, which is your health care consultancy in the German-speaking markets and allows you to keep up to date with market access , reimbursement and pricing issues in the D-A-CH countries and around the world. With MAP you will get a summary of core market access systems and processes as well as latest changes in regulations including statements and opinions of core decision makers and stakeholders from various countries. The CEO and founder of MArS is also the driver behind MAP: Dr. Stefan Walzer works in the f
-
111
How Can Europe Move from Innovation Paradox to Powerhouse, Cuno Moser?
In the latest episode of MAP – the Market Access Podcast, Dr. Stefan Walzer engages with Swiss healthcare strategist Cuno Moser to explore Europe's "innovation paradox" in healthcare. Despite its strengths in research, data quality, and clinical expertise, Europe struggles to transform pilot projects into scalable, reimbursable solutions. With over 27 fragmented reimbursement systems in the EU and in Switzerland, significant barriers impede progress in digital health, medtech, and AI-driven care. Beyond funding, challenges such as misaligned incentives, insufficient execution infrastructure, and flawed system design keep innovation stuck in "pilot purgatory."Looking ahead, while Europe may not lead in speed, it has the opportunity to excel in quality and trust. This could allow European health platforms to establish a competitive edge. If you're involved in digital health, medtech, AI, or market access and find your solution stalled between a promising pilot and real-world scalability, this episode is a must-listen.https://www.linkedin.com/feed/update/urn:li:activity:7437804838232453120/Stay connected by subscribing on your favorite podcast platform or listening directly on our website: MAP Podcasts —and if you enjoyed the episode, don’t forget to rate it and the podcast!MAP is the first and only bi-weekly market access podcast provided by MArS—and the global #1 podcast in the field of health economics. For more information about MArS Market Access and Pricing Strategy, visit: https://marketaccess4-0.com/#MarketAccess #Pharma #EuropeanHealthcare #Medtech #DigitalHealth #AIinHealthcare #mAxInsights #FromPilotToScale #InnovationParadox #ScalingHealthInnovation #QualityOverSpeed #MAPPodcast #marketaccess #marketaccesspodcast
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
Market Access (or alternatively reimbursement) in health care is THE key competence in order to be commercially successful with a new drug, medical device or digital health application. However, given the fact that market access is a complex field involving various disciplines and is an ever-changing field, it is difficult to be up to speed with the different evolvements across the world. MAP is THE bi-weekly Market Access Podcast provided by MArS Market Access & Pricing Strategy, which is your health care consultancy in the German-speaking markets and allows you to keep up to date with market access , reimbursement and pricing issues in the D-A-CH countries and around the world. With MAP you will get a summary of core market access systems and processes as well as latest changes in regulations including statements and opinions of core decision makers and stakeholders from various countries. The CEO and founder of MArS is also the driver behind MAP: Dr. Stefan Walzer works in the f
HOSTED BY
Dr. Stefan Walzer
Loading similar podcasts...
URL copied to clipboard!